ADVOCACY

Advocacy

Advocacy Overview
AMP v FDA

 

Coverage and Reimbursement

 

 

CLIA Clarification of LDPs
Laboratory-Developed Testing Procedures
Position Statements & Letters
Protecting Access to Medicare Act (PAMA)

The Protecting Access to Medicare Act of 2014 (PAMA) significantly revised the Medicare payment system for clinical diagnostic laboratory tests by requiring that payment rates under the Clinical Laboratory Fee Schedule (CLFS) be based on the weighted median of private payor rates, along with other related provisions.

Reports & White Papers
Reflecting on 10th Anniversary of AMP v. Myriad
Take Action

Corporate Partners